HIV Mutation Detail Information

> M184V Search Result


Mutation Information
Mutation Site M184V
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug dolutegravir (DTG)
Literature Information
PubMed PMID 33722682
Disease HIV infection/AIDS
Published Year 2021
Journal International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Title Dolutegravir response in antiretroviral therapy naïve and experienced patients with M184V/I: Impact in low-and middle-income settings.
Author Ndashimye E,Arts EJ
Evidence Lamivudine and emtricitabine associated M184V/I mutation is highly prevalent in PLWH and the majority of HIV infected individuals receiving DTG regimens may already be carrying M184V/I mutation.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation